Title: Orally active MMP-1 sparing α-tetrahydropyranyl and α-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.
Journal: Journal of medicinal chemistry 20100923
1197334-04-5 | 3,5-Dihydro-5-methyl-N-3-pyridinylbenzo[1,2-b | AA01ENNV | MFCD01530064
910484-32-1 | TTA-Q6(isomer) | AA01ENY1 | MFCD31657345
2016795-77-8 | EC330 | AA01EO2C | MFCD31382117
1231889-53-4 | BMS-935177 | AA01EO5Q | MFCD30470964
1964515-43-2 | LDH-IN-1 | AA01EOBO | MFCD31657379
1218816-71-7 | SK1-IN-1 | AA01EOGV | MFCD31382196
1610358-56-9 | (+)-BAY-1251152 | AA01EONA | MFCD31619237
1427325-32-3 | (2-hydroxy-1-pentyl-1H-indol-3-yl)(naphthalen-1-yl)-methanone | AA01EOTB | MFCD18382133
1630022-98-8 | [1-(5-fluoropentyl)-6-hydroxy-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)-methanone | AA01EP27
1646795-60-9 | 6Z-[2-oxo-4-(2-phenylethyl)-3-oxetanylidene],hexanamide | AA01EPCC